HealthyDirect · GrowthFit for a long SIP
Baroda BNP Paribas Short Term Fund (the scheme has 2 segregated portfolios)
Baroda BNP Paribas Mutual FundIncome/Debt Oriented Schemes - Short Term Fund13.8 years
The investment objective of the Scheme is to generate income from a portfolio constituted of short term debt and money market securities.
- NAV
- 33.9759
- 30 Oct 2026
- 1Y
- +4.6%
- Trailing CAGR
- AUM
- ₹419.27 Cr
- 30 Sept 2026
- Volatility
- Low
- 1.2% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 63% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.44% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -2.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
63% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Prashant R Pimple · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 40.0% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+4.6%
- 3Y+7.3%
- 5Y+6.5%
- 10Y+7.2%
- SI+7.8%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+4.6%
- 3Y+6.4%
- 5Y+6.8%
- 10Y+6.8%
- Since inception
- +7.8%
- Calendar-day CAGR
- Excess 1Y
- +0.2%
- Category median, same plan and option
- 3Y win rate
- +63%
- Windows beating the median
- 3Y percentile
- 63
- Vs comparable share classes
- SIP 3Y XIRR
- +6.4%
- Simulated monthly SIP
- Worst rolling 3Y
- +4.9%
- 2616 daily-ending windows
- Median rolling 3Y
- +8.2%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2133 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -2.1%
- Worst peak-to-trough
- Current
- -0.1%
- Below last peak
- Current spell
- 21 days
- Days below latest peak
- Time below peak
- +34%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 4 days
- 312 recovered episodes
- Longest recovery
- 84 days
- Trough to prior peak
9 Mar 2020 – 27 Mar 2020
Trough 23 Mar 2020 · recovered in 4 days
-2.1%
12 Jul 2013 – 19 Sept 2013
Trough 26 Jul 2013 · recovered in 55 days
-1.9%
7 Apr 2022 – 1 Aug 2022
Trough 9 May 2022 · recovered in 84 days
-1.5%
23 Apr 2020 – 8 Jun 2020
Trough 29 Apr 2020 · recovered in 40 days
-1.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
63
Vs category
51
Consistency
58
Risk-adjusted
100
Drawdown
95
Mean
73
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 63% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 52 holdings · top 10 are 40.0%.
- Top 5
- 23.6%
- Top 10
- 40.0%
- Largest holding
- 7.1%
- Effective holdings
- 36.0
Others CBLO
Unspecified
7.1%
SMALL INDUSTRIES DEVELOPMENT BANK OF INDIA SR VII 7.42 BD 12MR29 FVRS1LAC
Financial
4.7%
NATIONAL BANK FOR AGRICULTURE AND RURAL DEVELOPMENT SR 26D 7.01 BD 16MR29 FVRS1LAC
Financial
4.7%
NIRMA LIMITED SR VII TR C 8.50 NCD 07AP27 FVRS1LAC
Consumer Staples
3.6%
TATA PROJECTS LIMITED SR R 8.35 NCD 22JL27 FVRS1LAC
Industrials
3.6%
What changed
DECISION
Status moved from HEALTHY to MONITOR.
15 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
8 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mahindra Manulife Short Term Fund
Mahindra Manulife Mutual Fund
- 1Y
- +4.8%
- 3Y
- +7.5%
- Vol
- 0.9%
- Max DD
- -1.1%
- Sharpe
- 0.60
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Groww Short Term Fund
Groww Mutual Fund
- 1Y
- +4.9%
- 3Y
- +7.4%
- Vol
- 1.0%
- Max DD
- -1.2%
- Sharpe
- 1.52
- 3Y win
- +33%
- Lower volatility
- Shallower drawdown
- Lower TER
- Higher trailing returns
Axis Short Term Fund
Axis Mutual Fund
- 1Y
- +4.8%
- 3Y
- +7.6%
- Vol
- 1.5%
- Max DD
- -2.6%
- Sharpe
- 1.43
- 3Y win
- +97%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Nippon India Short Term Fund
Nippon India Mutual Fund
- 1Y
- +4.4%
- 3Y
- +7.4%
- Vol
- 1.4%
- Max DD
- -2.9%
- Sharpe
- 1.42
- 3Y win
- +73%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
BANK OF INDIA SHORT TERM FUND
Bank of India Mutual Fund
- 1Y
- +4.3%
- 3Y
- +7.5%
- Vol
- 6.4%
- Max DD
- -19.8%
- Sharpe
- 0.17
- 3Y win
- +66%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER